Skip to main content

Grafa News and Videos — Page 1055

Grafa Headlines

Latest

Grafa

Genmab presents subgroup data affirming epcoritamab combination success across lymphoma risk brackets

Genmab (NASDAQ:GMAB) announced new data from a post-hoc subgroup analysis of its pivotal Phase 3 EPCORE FL-1 trial, which evaluates the subcutaneous T-cell engaging bispecific antibody epcoritamab in combination with rituximab and lenalidomide (epcoritamab plus R2).

Read more: Genmab presents subgroup data affirming epcoritamab combination success across lymphoma risk brackets

Grafa
Auto and cars

Driven Brands rebounds in first quarter led by Take 5 expansion

Driven Brands Holdings (NASDAQ:DRVN) reported a rise in profit and revenue for the first quarter of fiscal 2026, supported by robust performance in its quick-lube business even as the company navigates elevated corporate expenses stemming from its recent financial restatements.

Read more: Driven Brands rebounds in first quarter led by Take 5 expansion

GET YOUR GRAFA EDGE NOW

We'll switch on a 30-day Edge trial as a welcome gift